Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab

NCT01022086 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Stage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic)

Interventions

PROCEDURE: Cardiac MRI
BIOLOGICAL: Biomarker Testing

Sponsor

Unity Health Toronto

Collaborators

[object Object]